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γ-Aminobutyric acid (GABA) depolarizes embryonic cerebrocortical neurons and continuous
activation of the GABAA receptor (GABAAR) contributes to their tonic depolarization.
Although multiple reports have demonstrated a role of GABAAR activation in neocortical
development, including in migration, most of these studies have used pharmacological
blockers. Herein, we performed in utero electroporation in GABA synthesis-lacking
homozygous GAD67-GFP knock-in mice (GAD67GFP/GFP) to label neurons born in the
ventricular zone. Three days after electroporation, there were no differences in the
distribution of labeled cells between the genotypes. The dose–response properties of
labeled cells to GABA were equivalent among genotypes. However, continuous blockade
of GABAAR with the GABAAR antagonist SR95531 accelerated radial migration. This
effect of GABA R blockade in GAD67GFP/GFPA mice suggested a role for alternative
endogenous GABAAR agonists. Thus, we tested the role of taurine, which is derived from
maternal blood but is abundant in the fetal brain. The taurine-evoked currents in labeled
cells were mediated by GABAAR. Taurine uptake was blocked by a taurine transporter
inhibitor, 2-(guanidino)ethanesulfonic acid (GES), and taurine release was blocked by
a volume-sensitive anion channel blocker, 4-(2-butyl-6,7-dichlor-2-cyclopentylindan-1-on-5-
yl) oxobutyric acid, as examined through high-performance liquid chromatography. GES
increased the extracellular taurine concentration and induced an inward shift of the holding
current, whichwas reversed by SR95531. In a taurine-deﬁcientmousemodel, the GABAAR-
mediated tonic currents were greatly reduced, and radial migration was accelerated. As
the tonic currents were equivalent among the genotypes of GAD67-GFP knock-in mice,
taurine, rather than GABA, might play a major role as an endogenous agonist of embryonic
tonic GABAAR conductance, regulating the radial migration of neurons in the developing
neocortex.
Keywords: taurine, GABAA receptor, tonic current, radial migration, non-vesicular release, volume-sensitive anion
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INTRODUCTION
During the development of the nervous system, cortical neurons
are generated in the ventricular zone (VZ; Sidman andRakic, 1973;
Caviness andRakic, 1978). After terminalmitosis, neurons derived
from the VZ migrate radially through the cell-sparse intermediate
zone (IZ) into the cortical plate (CP) to give rise to glutamatergic
neurons of the neocortex, such as pyramidal and stellate neurons
(Tan et al., 1998; Andjelic et al., 2009). During the early devel-
opmental stage of cortical neurons, functional GABAA receptors
(GABAAR) are present on both proliferative and early postmi-
totic cells (LoTurco et al., 1995; Owens et al., 1996). Furthermore,
GABAAR activation can regulate the migration of neuronal pre-
cursors (Komuro and Rakic, 1998; Nadarajah and Parnavelas,
2002; Marin and Rubenstein, 2003). In the developing cerebral
cortex, activation of GABAAR modulates radial migration as a
stop signal (Behar et al., 1998; Heck et al., 2007). GABAARs on
neural precursor cells in the postnatal subventricular zone (SVZ)
are activated tonically, which reduces the migration speed of the
cells (Bolteus and Bordey, 2004; Bolteus et al., 2005). Tonic activa-
tion of GABAARs is also evident in embryonic neurons before
synapse formation has occurred (Valeyev et al., 1993; LoTurco
et al., 1995; Owens et al., 1999; Demarque et al., 2002). The effects
of GABAAR activation on neuronalmigration have been described
using GABAAR antagonists in cultured brain slices and dissociated
cells (Behar et al., 1996, 1998, 2000; Bolteus and Bordey, 2004).
However, most reports have only focused on the role of GABAAR
in cortical cell migration assuming that under natural conditions,
these receptors are activated by GABA. However, this hypothesis
has never been directly tested, and the roles of other endogenous
GABAAR agonists have not been addressed.
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GABA is one of the earliest neurotransmitters detectable in
the developing central nervous system (CNS; Lauder et al., 1986;
Behar et al., 1993; Ma and Barker, 1995) and is synthesized from
glutamic acid by glutamic acid decarboxylase (GAD). The GAD67
isoform of GAD is expressed in GABAergic interneurons. GAD67-
expressing cells originating from ganglionic eminences migrate
tangentially and become distributed in the developing cerebral
cortex (Tamamaki et al., 2003). It is generally thought that GABA
from GAD67-expressing cells activates GABAARs and plays an
important role in radial migration. However, the gross structure
of the brain appears normal in new-born GAD67 knock-out mice
(Asada et al., 1997; Ji et al., 1999), which is inconsistent with a
role of GABA in radial migration. Thus, it is also possible that
the GABAARs of radially migrating cells may be activated by
endogenous ligands other than GABA.
In the CNS, taurine (2-aminoethanesulfonic acid) is the most
abundant amino acid (Kontro et al., 1984;Huxtable,1989; Benitez-
Diaz et al., 2003). Taurine is an endogenous partial agonist of the
GABAAR and induces chloride currents in neurons (Linne et al.,
1996; Ye et al., 1997). Although the capacity to synthesize taurine is
low during fetal life (Hayes and Sturman, 1981; Kuo and Stipanuk,
1984; Ghisolﬁ, 1987), taurine levels are higher in the immature
brain than in the adult brain (Kaczmarek, 1976; Benitez-Diaz et al.,
2003). Inmammals, sufﬁcient taurine for embryonic development
is received from themother via the placenta, while neonates obtain
taurine from their mothers’ milk (Sturman et al., 1977; Sturman,
1981). Taurine exhibits physiological actions as a trophic factor
and as a neuromodulator during the development of the CNS
(Sturman, 1993; Oja and Saransaari, 1996; Hernandez-Benitez
et al., 2012). In taurine-deﬁcient kittens, the migration of granule
cells from the external granule cell layer to the inner layers of the
cerebellum is delayed (Sturman et al., 1985). Although the phys-
iological properties of taurine in the developing brain have been
described, it is not yet known whether endogenous taurine acti-
vates GABAARs and modulates radial migration in the developing
cerebral cortex.
In the present study, we hypothesized that taurine activates
GABAAR tonically and affects radial migration of neurons in
the developing cerebral cortex. Similar to GAD67 knock-out
mice, GABA levels are decreased in heterozygous (GAD67+/GFP)
and homozygous (GAD67GFP/GFP) GAD67-GFP knock-in mice
(Tamamaki et al., 2003; Morishima et al., 2010). Furthermore, tau-
rine synthesis can be suppressed via the intraperitoneal injection
of D-cysteinesulﬁnic acid (D-CSA; Weinstein et al., 1988), and it
has been reported that a low maternal taurine level results in low
taurine levels in the fetus (Aerts andVanAssche,2002). Thus, using
GAD67-GFP knock-in mice and D-CSA, we examined the effects
of the taurine activation of GABAAR on radial migration in the
developing mouse cerebral cortex. Our results provide evidence
of taurine-mediated tonic activation of GABAARs and reveal that
taurine retards radial migration in the developing mouse cerebral
cortex.
MATERIALS AND METHODS
ETHICAL APPROVAL
All experiments conformed to the guidelines issued by the Hama-
matsu University School of Medicine for the ethical use of animals
for experimentation, and all efforts were made to minimize the
number of animals used and their suffering.
ANIMALS
The generation of GAD67-GFP (neo) mice has been described
previously (Tamamaki et al., 2003). In the present study, female
heterozygous (GAD67+/GFP) mice were placed overnight with
male (>9 weeks) GAD67+/GFP mice in a cage under a 12-h
light–dark cycle (lights off from 19:00 to 07:00). The day on
which a virginal plug was observed in the morning was desig-
nated as embryonic day 0.5 (E0.5). Polymerase chain reaction
(PCR) ampliﬁcation was performed to discriminate the genotypes
of individuals. For some experiments, we used also Wistar rats
purchased from Japan SLC (Hamamatsu, Japan).
IN UTERO ELECTROPORATION
Cells were transfected in vivo through in utero electroporation,
as described previously (Inoue et al., 2012). Brieﬂy, plasmids car-
rying monomeric red ﬂuorescent protein (mRFP) downstream
of a CAG promoter (Addgene, MA, USA) were prepared using
the EndoFree Plasmid Kit (Qiagen, Hilden, Germany). Preg-
nant mice and rats were anesthetized with sodium pentobarbital
(50 mg/kg intraperitoneally) at E14.5 and E15.5, respectively,
and their uterine horns were exposed. Plasmid DNA was dis-
solved in phosphate buffered saline (PBS) at a ﬁnal concentra-
tion of 0.5 μg/μl with Fast Green (ﬁnal concentration 0.05%
[v/v]). Plasmids were injected into the lateral ventricle using
a glass micropipette and a controlled pipette system (IM-30,
Narishige, Tokyo, Japan). The micropipettes were generated
from glass capillaries (outer diameter 1.0 mm; Harvard Appa-
ratus, South Natick, MA, USA) that were pulled using a P-97
micropipette puller (Sutter Instrument Co., Novato, CA, USA).
Electric pulses were produced by an electroporator (CUY21EDIT;
NepaGene, Ichikawa, Japan) and delivered by a round plate
forceps-type electrode with a 5-mm diameter (CUY650P5; Nepa-
Gene). Electric pulses (43 V, 50 ms) were applied ﬁve times at
intervals of 950 ms. The uterine horns were then returned to the
abdomen.
IMPLANTATION OF PLGA FOR SUSTAINED DRUG ADMINISTRATION
IN VIVO
Copoly(d,l-lactic/glycolic acid) (PLGA) exhibits high bio-afﬁnity
and biodegradability and is therefore a useful material for
achieving sustained drug release (Miller et al., 1977). PLGA
(20 mg; Wako, Osaka, Japan) was dissolved in 100 μl of N-
methyl-2-pyrrolidone (Wako; Kranz et al., 2001), and 10 μl
of 10 mM SR95531 or water (Control) was added. Follow-
ing in utero electroporation, the PLGA solution or SR95531-
adsorbed PLGA (0.5 μl) was injected into the lateral ventricles of
fetuses.
ANALYSIS OF RADIAL MIGRATION BASED ON DISTRIBUTION
PATTERNS OF NEURONS
Fetuses were killed at E17.5 and decapitated, and their brains were
dissected out. The brains were ﬁxed in 4% paraformaldehyde
for 3 h at 4◦C and then transferred to 30% sucrose phosphate
buffer (0.1 M, pH 7.4) and left immersed for 3 days. The brains
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were then sectioned coronally at a thickness of 30 μm using a
cryostat and counterstained with 4′,6-diamidino-2-phenylindole
(DAPI) to indicate proliferative zones, after which the sections
were transferred to slides and coverslipped. Images were subse-
quently captured using a cooled charge-coupled device (CCD)
camera (Orca ER-G; Hamamatsu photonics, Hamamatsu, Japan)
attached to an epiﬂuorescence microscope (BX-51; Olympus,
Tokyo, Japan). The E17.5 neocortex is laminated into the marginal
zone (MZ), CP, subplate (SP), IZ, and SVZ/VZ (Shinozaki et al.,
2007). Based on the cytoarchitecture revealed by DAPI coun-
terstaining, the regions with abundant cells were considered the
SVZ/VZandCP.The IZ andSPweredeﬁned as the regions between
these areas (Caric et al., 1997; Inoue et al., 2012). The boundary
between the IZ and SP was assessed based on the DAPI signal
density, which was higher in the IZ than the SP. To determine
the distribution pattern of migrating neurons, all of the red ﬂuo-
rescent protein (RFP)-positive cells in the cortex of each section
were counted. The area in which GFP-positive cells were counted
was approximately 300 μm wide and included the full thickness
of the cortex. The numbers of RFP- or GFP-positive cells in the
MZ, CP, SP, IZ, and SVZ/VZ were counted using ImageJ software
(National Institutes of Health, Bethesda, MD, USA). The RFP- or
GFP-positive cells in each area were counted and are presented as
the ratio to the number of counted cells in a slice.
HISTOLOGY AND IMMUNOHISTOCHEMISTRY
Taurine localization was observed immunohistochemically. The
fetal neocortex of E17.5 mice was ﬁxed via perfusion with 4%
paraformaldehyde/0.5% glutaraldehyde in 0.1 M Tris buffer (TB).
The brains were removed and immersed in the same ﬁxative for
3 h at 4◦C. After post-ﬁxing, the brains were transferred to 15%
sucrose TB for 1 h and 30% sucrose TB for 3 days. Tissues were
cut coronally with a cryostat into sections with a thickness of
30 μm and rinsed in Tris-buffered saline (TBS). The sections
were ﬁrst treated with 0.5% NaBH4, then incubated for 0.5 h in
0.3% H2O2 in TBS and subsequently with an antibody against
taurine (TT100, polyclonal rabbit IgG; Signature Immunologics,
Salt Lake City, UT, USA) for 36 h at 4◦C. After rinsing in TBS,
the sections were incubated for 1 h with a secondary antibody
against rabbit IgG (anti-rabbit biotinylated, BA1000; Vector Lab-
oratories, Burlingame, CA, USA). The primary and secondary
antibodies were diluted in TBS containing 2% horse serum albu-
min and 0.1% Triton X-100. Visualization was performed using
the Biotin/Avidin system (Vector Laboratories). Sections were
treated in diaminobenzidine (DAB). After rinsing, the sections
were mounted on slides and coverslipped and ﬁnally observed
under a microscope (AX-80; Olympus) equipped with a CCD
camera (EP-70; Olympus).
ELECTRON MICROSCOPY
After deeply anesthetizing the animals via hypothermia
and perfusing them transcardially with 4% paraformalde-
hyde/0.5% glutaraldehyde in 0.1 M 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) buffer, their brains were
removed and post-ﬁxed for 10 min. Coronal sections (50 μm)
were cut with a vibratome (DTK-1500; Dosaka, Kyoto, Japan) in
the same ﬁxative solution. The sections were incubated in 0.1 M
HEPES buffer for 1 day at 4◦C. After rinsing in PBST (0.1% Triton
X-100/0.1 M PBS) three times, the sections were incubated for 1 h
in blocking buffer containing 2% horse serum albumin and 0.1%
TritonX-100, then incubated for 36 h at 4◦Cwith a polyclonal anti-
body against taurine (Signature Immunologics). The sectionswere
subsequently washed with PBS three times, incubated in blocking
buffer for 1 h at room temperature, and then treated with an anti-
rabbit secondary antibody coupled with 1.4-nm diameter gold
particles (Nanogold; Nanoprobes, Yaphank, NY, USA) overnight
at room temperature. After this step, an immunoelectron micro-
scopic analysis was performed by Tokai Electron Microscopy Inc.
(Nagoya, Japan). After the sectionswerewashedwithPBS andﬁxed
in 2% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4)
for 3 h at room temperature, the gold particles were enlarged for
microscopic examination with the HQ-Silver Enhancement Kit
(Nanoprobes) and routinely processed for electron microscopic
examination. The embedded samples were sectioned (thickness
80 nm) with an ultra-microtome (LKB2088; LKB, Bromma, Swe-
den) and stained with uranyl acetate and lead citrate. The sections
were then carbon-coated in a vacuum and observed with a JEOL
transmission electron microscope (JEM 2000EX; JEOL, Tokyo,
Japan) at 100 kV.
ACUTE SLICE PREPARATION
Coronal cortical slices were obtained from mouse fetuses at E17.5
(or rat fetuses at E18.5). The maternal mice or rats were deeply
anesthetized via inhalation of halothane, and the fetal brains were
rapidly removed and placed in cold (4◦C), oxygenated, modi-
ﬁed artiﬁcial cerebrospinal ﬂuid (ACSF). The solution contained
the following components (in mM): 220 sucrose, 2.5 KCl, 1.25
NaH2PO4, 10.0 MgSO4, 0.5 CaCl2.2H2O, 26.0 NaHCO3, and 30.0
glucose (330–340 mOsm). Coronal slices (400 μm) were cut in
the modiﬁed ACSF using a vibratome (VT-1000; Leica, Wetzlar,
Germany). The slices were maintained in oxygenated standard
ACSF consisting of (in mM) 126 NaCl, 2.5 KCl, 1.25 NaH2PO4,
2.0 MgSO4, 2.0 CaCl2, 26.0 NaHCO3, and 20.0 glucose gassed
with 95% O2–5% CO2 at room temperature prior to recording.
Individual slices were transferred to a recording chamber, per-
fused (2 ml/min) with pre-gassed standard ACSF, and maintained
at 30◦C.
ELECTROPHYSIOLOGY
In all of the electrophysiological experiments, D-(-)-2-amino-
5-phosphonopentanoic acid (D-AP5, 50 μM), 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX, 10 μM), CGP55845 (3 μM),
and tetrodotoxin (TTX, 0.5 μM) were added to the ACSF. Patch
electrodeswere fabricated from1.5-mmdiameter borosilicate cap-
illary tubing (GD-1.5; Narishige) using a P-97 horizontal puller
(Sutter Instruments). The electrode resistance ranged from 7 to
10 M when the electrode was ﬁlled with a solution contain-
ing (in mM) 110 CsCl, 6 MgCl2, 10 ethylene glycol tetraacetic
acid (EGTA), 10 HEPES, 4 K2-ATP, 20 K2-phosphocreatine, and
50 U creatine phosphokinase. The pH was adjusted to 7.3 with
CsOH. Under these experimental conditions, GABAergic IPSCs
(inhibitory postsynaptic currents) reversed at approximately 0mV
(the ECl predicted by the Nernst equation). With the cells
voltage-clamped at −60 mV, the GABAergic IPSC appeared as an
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inward current. The recorded currents were ﬁltered at 2 kHz and
digitized at 1–10 kHz using DigiData1322A and pCLAMP9 soft-
ware (Molecular Devices, Sunnyvale, CA, USA). GABA, taurine,
and glycine were added through another pipette to the recorded
cell soma using a puffer application system (IM-300; Narishige).
The data were analyzed using Clampﬁt9 (Molecular Devices).
Dose–response relationships forGABAwereﬁtted to theHill equa-
tion: I = Imax/{1 + [EC50/(GABA)]n}, where I is the peak current
measured at a given concentration of GABA; Imax is the current at
the maximal GABA concentration; the EC50 is the half-maximal
effective GABA concentration; and n is the Hill coefﬁcient. Ligand
applications were separated by 3 min intervals to allow recovery
from desensitization when present.
MEASUREMENT OF AMBIENT GABA AND TAURINE
Ambient GABA and taurine levels were measured using high-
performance liquid chromatography (HPLC) methods. Following
the preparation of tissue slices, the cerebral cortex was cut from
two coronal slices. The cortices were equilibrated for 1 h in
a holding chamber ﬁlled with continuously oxygenated ACSF.
In taurine loading experiments, 1 or 10 mM taurine was dis-
solved in the ACSF. After 1 h of incubation with or without
taurine, the cortices were rinsed thoroughly and placed in a
submerged-type small chamber ﬁlled with ACSF that was oxy-
genated and ﬁltered (Minisart; Sartorius, Göttingen, Germany)
and incubated for 1 h at 30◦C. Hypotonic medium consisting
of (in mM) 31 NaCl, 2.5 KCl, 1.25 NaH2PO4, 2.0 MgSO4, 2.0
CaCl2, 26.0 NaHCO3, and 20.0 glucose gassed with 95% O2–5%
CO2, was used for hypotonic stimulation. In some experiments,
drugs were dissolved in ACSF in the small chamber to inhibit
taurine transporter or anion channel. The supernatant (120 μl)
was subsequently collected and stored at −80◦C until HPLC anal-
ysis. After the samples were derivatized with o-phthalaldehyde,
the concentrations of amino acid neurotransmitters were deter-
mined via reverse-phase HPLC with electrochemical detection.
The HPLC system (BAC-300 system; EICOM, Kyoto, Japan)
consisted of an EP-300 pump, an ECD-300 electrode and a Pow-
erChrom system (ADInstruments, Sydney, Australia). Separation
of amino acid derivatives was achieved using an Eicompack MA-
5ODS column (150 mm × 3 mm, EICOM) kept at 30◦C. The
detection potential was set at +700 mV against an Ag/AgCl
reference electrode. The ﬂow rate was 0.5 ml/min, and the
sensitivity was set at 64 nA/V full-scale. The mobile phase con-
sisted of (in mM) 86.2 NaH2PO4.2H2O, 13.8 Na2HPO4.12H2O,
0.015 EDTA.2Na, and 30% (v/v) methanol at pH 6.0 and was
membrane ﬁltered (0.45 μm) and degassed (DG-300; EICOM)
at a ﬂow rate of 0.5 ml/min (EP-300). The amino acids and
the derivatives were mixed and allowed to react for exactly
2 min before injection. The amino acid derivatives were then
detected electrochemically. Sample concentrations were deter-
mined based on comparison of peak areas with that of an external
standard.
D-CYSTEINESULFINIC ACID ADMINISTRATION
Taurine is formed via the oxidation of hypotaurine, an interme-
diate generated by L-type cysteinesulﬁnic acid (L-CSA) decar-
boxylation. L-CSA is formed by the oxidation of cysteine and
is the main taurine precursor in rodents. D-CSA is used as
a metabolism-resistant, potent and speciﬁc inhibitor of L-CSA
decarboxylase (Weinstein et al., 1988; Dominy et al., 2004). After
electroporation, D-CSA (15 mmol/kg) was administered every
12 h via maternal intraperitoneal injection. As a control group,
saline was administered to other mice at the same interval. D-CSA
was custom synthesized from D-cysteine using D-cysteine thiosul-
fonate according to a previously reported procedure (Emiliozzi
and Pichat, 1959).
DRUGS
The following drugs were used: SR95531, bicuculline methiodide,
and strychnine (Sigma-Aldrich, St. Louis, MO, USA); CNQX, D-
AP5, picrotoxin, bumetanide, and 2-(guanidino)ethanesulfonic
acid (GES),CGP55845 (Tocris Bioscience, Bristol, UK); PLGA and
TTX (Wako); 4-(2-butyl-6,7-dichlor-2-cyclopentylindan-1-on-5-
yl) oxobutyric acid (DCPIB; Santa Cruz Biotechnology, Santa
Cruz, CA, USA); 4,4′-diisothiocyanatostilbene-2,2′-disulfonic
acid (DIDS; Invitrogen, Carlsbad, CA,USA); and D-cystine (Acros
Organics, Fair Lawn, NJ, USA).
STATISTICS
Unless otherwise indicated, all numerical data are presented as
the mean ± SEM. Differences between two groups were assessed
using Student’s t-test for absolute values and theMann–WhitneyU
(MWU)-test for normalized values. Comparisons among several
groups were performed via one-way ANOVA. The distribution
patterns of radially migrating cells were compared using chi-
square tests (χ2-tests). Differences were considered statistically
signiﬁcant at P < 0.05.
RESULTS
THE DISTRIBUTION OF RADIALLY MIGRATING CORTICAL PLATE CELLS
DOES NOT DIFFER BETWEEN WILD-TYPE AND GAD67-GFP KNOCK-IN
MICE
We previously demonstrated that the ambient levels of GABA in
the cerebral cortices of heterozygous (GAD67+/GFP) and homozy-
gous (GAD67GFP/GFP) GAD67-GFP knock-in fetuses were 67.8
and 12.7%, respectively, of the level in wild-type (GAD67+/+)
fetuses (Morishima et al., 2010). Thus, GAD67-GFP knock-in
mice are suitable for investigating the inﬂuence of decreased
ambient GABA levels on the radial migration of neurons during
neocortical development. We performed in utero electroporation
to label radially migrating neurons with RFP at E14.5. Three
days after electroporation (E17.5), we analyzed the distribution
of RFP- and GFP-positive cells across the proliferative and the
migratory zones of the neocortex in cortical slices. The bound-
aries of individual zones were determined based on differences
in cell density revealed by DAPI counterstaining (Figure 1C).
RFP-positive cells were mainly distributed in the CP, SP, and IZ
in all three genotypes of fetuses (Figure 1A). In GAD67+/GFP
and GAD67GFP/GFP fetuses, GFP-positive cells were also dis-
tributed in the MZ (Figure 1B). There were no cells expressing
both RFP and GFP, conﬁrming that the radially migrating neu-
rons were different from the GABAergic neurons. The RFP- and
GFP-positive cells in each region were counted and are presented
as the percentages of total RFP- and GFP-positive cells in the
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FIGURE 1 | Distribution patterns of radially migrating neurons and
tangentially migrating GABAergic neurons in the cerebral cortex at
E17.5. (A) Distribution of radially migrating neurons expressing mRFP (red ) in
a coronal section of the neocortex of a GAD67+/GFP fetus. (B) Distribution of
GABAergic neurons expressing GFP (green) in the same section. (C)The
section was counterstained with DAPI. The dotted lines in (A–C) indicate the
boundaries of the proliferative and migratory zones. The scale bar represents
200 μm. MZ, marginal zone; CP, cortical plate; SP, subplate; IZ, intermediate
zone; SVZ, subventricular zone; VZ, ventricular zone. (D) Percent distributions
of RFP-positive cells in the CP, SP, IZ, and SVZ/VZ averaged over ﬁve
GAD67+/+ fetuses, four GAD67+/GFP fetuses, and ﬁve GAD67GFP/GFP
fetuses. (E) Percent distributions of GFP-positive cells in the MZ, CP/SP, IZ,
and SVZ/VZ (GAD67+/+: n = 4; GAD67+/GFP: n = 5). Error bars indicate the
mean ± SEM.
neocortex, respectively (Figures 1D,E). There were no signiﬁcant
differences in the distribution patterns of RFP- and GFP-positive
cells between the genotypes (P = 0.925 for RFP-positive cells,
Figure 1D; P = 0.833 for GFP-positive cells, Figure 1E; χ2-test).
Thus, these data suggest that the radial migration of neurons in
the neocortex was not affected by decrements in ambient GABA
levels.
THE SENSITIVITY OF GABAARs IN RADIALLY MIGRATING NEURONS
DOES NOT DIFFER BETWEEN WILD-TYPE AND GAD67-GFP KNOCK-IN
MICE
Previous studies have shown that functional GABAARs are present
in developing neocortical cells (LoTurco et al., 1995; Owens et al.,
1996). To examine the sensitivity of GABAARs to GABA in wild-
type and GAD67-GFP knock-in fetuses, we examined the currents
elicited via puff application of GABA in RFP-positive, radi-
ally migrating neurons in all three genotypes. Under whole-cell
voltage-clamp conditions at −60 mV, the application of GABA (3–
300μM)produced inward currents in all of the testedRFP-positive
neurons (Figure 2A). The dose dependence of the peak amplitude
of the current on GABA was ﬁtted with a Hill equation (see Mate-
rials and Methods), and the dependence was examined in each
plate/zone of the neocortex. The EC50s and Hill coefﬁcients of the
current responses were approximately 18 μM and 1.3, respectively,
in all GAD67+/+, GAD67+/GFP, and GAD67GFP/GFP fetuses, and
there were no signiﬁcant differences in these values between the
genotypes or between the plates and zones (Figure 2B). Thus,
these data indicate that the sensitivity of GABAARs between the
genotypes does not differ at any of the migration stages of radially
migrating neurons.
BLOCKADE OF GABAARs IN VIVO INCREASES THE RADIAL MIGRATION
SPEED IN GAD67GFP/GFP MICE
We showed that the distribution pattern and GABAAR sensitivity
of radially migrating neurons were normal, even in GABA-
deﬁcient GAD67GFP/GFP mice (Figures 1 and 2). These results
suggest the possibility that GABAARs might not be involved in
radialmigration. To test this hypothesis, we continuously adminis-
tered the selectiveGABAAR antagonist SR95531 toGAD67GFP/GFP
fetuses via intra-ventricular injection. SR95531-adsorbed PLGA
was injected into the lateral ventricles of GAD67GFP/GFP fetuses
immediately after in utero electroporation at E14.5. Three days
after PLGA injection, the distribution pattern of RFP-positive
cells was analyzed. SR95531 administration signiﬁcantly altered
the distribution pattern of RFP-positive cells compared with the
Control injected with drug-free PLGA (P = 0.049 by χ2-test, n = 6
in Control, n = 6 in SR95531; Figure 3). The numbers of RFP-
positive cells were signiﬁcantly increased in the CP and decreased
in the SP and IZ following SR95531 administration (P = 0.001
in CP, P = 0.014 in SP, P = 0.002 in IZ by MWU-test, n = 6 in
Control, n = 6 in SR95531; Figure 3B). This indicates an acceler-
ation of radial migration induced by SR95531 in GAD67GFP/GFP
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FIGURE 2 |The sensitivity of GABAARs to GABA in RFP-positive cells in
the E17.5 cerebral cortex does not differ between wild-type and
GAD67-GFP knock-in mice. (A) Representative GABA-evoked currents
recorded in an RFP-positive cell from a GAD67+/+ fetus. The holding
potential (VH) was −60 mV. The puff application of GABA was stopped
immediately after desensitization was initiated. (B) Dose–response curves of
GABA currents. The EC50s of the current responses in GAD67+/+,
GAD67+/GFP, and GAD67GFP/GFP fetuses were 16.23 ± 1.75, 17.46 ± 2.11,
and 19.22 ± 2.43 μM, respectively, in the CP/SP (P = 0.657 by ANOVA);
16.98 ± 1.80, 20.28 ± 1.13, and 18.53 ± 2.64 μM, respectively, in the IZ
(P = 0.512); and 16.24 ± 2.61, 18.79 ± 1.66, and 20.39 ± 2.12 μM,
respectively, in the SVZ/VZ (P = 0.422). The Hill coefﬁcients were 1.36 ± 0.13,
1.26 ± 0.08, and 1.34 ± 0.07, respectively, in the CP/SP (P = 0.696);
1.49 ± 0.11, 1.28 ± 0.10, and 1.28 ± 0.08, respectively, in the IZ (P = 0.295);
and 1.33 ± 0.11, 1.28 ± 0.10, and 1.23 ± 0.16, respectively, in the SVZ/VZ
(P = 0.891). Error bars: mean ± SEM.
fetuses, suggesting that under normal conditions, GABAARs are
activated and play a role in slowing the radial migration speed,
even in GAD67GFP/GFP fetuses, where the ambient GABA level in
the neocortex is very low. These data suggest that another endoge-
nous GABAAR agonist might activate the GABAARs of radially
migrating cells.
LOCALIZATIONS OF TAURINE AND TAURINE TRANSPORTERS IN THE
MZ AND SP OF THE DEVELOPING CEREBRAL CORTEX AT E17.5
Next, we examined the hypothesis that the GABAAR agonist
taurine might play a role in regulating radial migration in
GAD67GFP/GFP fetuses. To investigate taurine localization in the
developing cerebral cortex at E17.5, we performed immuno-
histochemical analyses in GAD67+/+ mice. Immunoreactivity
for taurine was prominent in the MZ and SP (Figures 4A–C).
To further identify the precise location of taurine in the
cells, we next performed immunoelectron microscopic observa-
tions using a taurine antibody. Taurine immunoreactivity was
present intracellularly and was diffusely located in the cytosol
(Figure 4D). In the examined specimens, neither presynaptic
structures such as synaptic vesicles nor postsynaptic densities were
observed.
Taurine is transported into cells by taurine transporters, which
have been reported to be expressed in the developing brain (Smith
et al., 1992). The localization of taurine transporters in the cere-
bral cortex was also examined in GAD67+/+ fetuses at E17.5.
Immunoreactivity for taurine transporters was observed in the
MZ and SP, which are the same regions where taurine immunore-
activity was found (Figures 4E,F). These data suggest that taurine
accumulates in cells in the MZ and SP, where it may be released to
activate GABAARs on radially migrating cells.
TAURINE EVOKES GABAAR-MEDIATED CURRENTS IN RADIALLY
MIGRATING CELLS
Taurine is known to act as an agonist of glycine receptors (GlyRs).
GlyRs have been reported to be activated non-synaptically dur-
ing early neocortical development in rat fetuses (Flint et al.,
1998). In addition, taurine may act as a full agonist or a par-
tial agonist of GABAARs (Dominguez-Perrot et al., 1996). To
test whether taurine activates GlyRs or GABAARs in radially
migrating neurons, we compared the currents evoked by the
application of GABA, taurine, and glycine in RFP-positive cells
located in the SP of the cortices of GAD67+/+ fetuses at E17.5
and examined the effects of blockers of GABAARs and GlyRs on
these currents. The peak amplitude of GABA (10 μM)-evoked
inward currents was 46.20 ± 7.78 pA/pF (n = 10; Figures 5A,D,
left), and these currents were not blocked by the selective GlyR
antagonist strychnine (10 μM: 91.29 ± 6.01%, P = 0.161 by
paired t-test, n = 10; Figures 5A,D,E, left), whereas they were
blocked by SR95531 (10 μM: 7.54 ± 1.41%, P < 0.001, n = 9;
Figures 5A,D,E, left). Indeed, taurine (10 mM) evoked inward
currents (13.13 ± 1.57 pA/pF, n = 10; Figures 5B,D, left), which
were also not blocked by strychnine (94.44 ± 7.50%, P = 0.455,
n = 10; Figures 5B,D,E, left) but were blocked by SR95531
(17.42 ± 2.32%, P < 0.001, n = 9; Figures 5B,D,E, left). The
application of glycine (3 mM) did not produce any currents in
RFP-positive cells (1.45 ± 0.18 pA/pF, n = 10; Figures 5C,D, left).
Thus, radially migrating neurons in fetal mouse cortices do not
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FIGURE 3 | Sustained administration of a GABAAR antagonist
facilitates radial migration in GAD67GFP/GFP fetuses. (A)
Photomicrographs showing the distribution of RFP-positive cells in Control
(upper) and SR95531-treated (lower) GAD67GFP/GFP fetuses at E17.5.
PLGA with or without SR95531 was injected into the lateral ventricles of
GAD67GFP/GFP fetuses at E14.5, immediately after the electroporation of
RFP vectors. (B) Proportions of radially migrating cells in the CP, SP, IZ, and
SVZ/VZ. The distribution pattern of RFP-positive cells in SR95531-treated
GAD67GFP/GFP fetuses was signiﬁcantly different from that in Control,
untreated fetuses (χ2-test, $P < 0.05; Control: n = 6, SR95531-treated:
n = 6). The percentage of RFP-positive cells was increased in the CP and
decreased in the SP and IZ by SR95531 administration (*P < 0.05,
**P < 0.01). Error bars: mean ± SEM. Scale bar: 200 μm.
exhibit functional GlyRs, and taurine activates GABAARs in these
neurons.
We also examined the currents in RFP-negative cells for
comparison and found that glycine could evoke strychnine-
sensitive inward currents in six out of seven recorded cells
(50.08 ± 25.71 pA/pF, 21.78 ± 8.20% in the presence of strych-
nine, n = 6; Figures 5C–E, right). Thus, some RFP-negative cells
express functional GlyRs. GABA and taurine were able to elicit
SR95531-sensitive inward currents in the RFP-negative neurons
responsive to glycine, but the taurine-evoked currents were also
blocked weakly by strychnine in these neurons (60.14 ± 18.06%,
P = 0.205, n = 6; Figures 5B,D,E, right), and the GABA-
evoked currents were blocked more weakly (78.84 ± 14.10%,
P = 0.372, n = 6; Figures 5A,D,E, right). This indicates
that the RFP-negative cells possessing GlyRs also respond to
taurine.
The insensitivity of RFP-positive cells to glycine (Figures 5C,D)
appears to be inconsistent with ﬁndings in rat fetuses (Flint et al.,
1998; Nimmervoll et al., 2011). Therefore, we also examined the
currents in RFP-positive cells in cortical slices obtained from
rat fetuses at E18.5. The peak amplitudes of GABA (10 μM)-
evoked inward currents recorded in RFP-positive cells located
in the CP of rat cortices were 19.66 ± 3.22 pA/pF (n = 6;
Figures 6A,D), and these currents were not blocked by strych-
nine (10 μM: 74.92 ± 7.84%, P = 0.062 by paired t-test,
n = 6; Figures 6A,D,E) but were blocked by SR95531 (10 μM:
14.25 ± 3.07%, P < 0.001, n = 6; Figures 6A,D,E). Taurine
(10 mM) also evoked inward currents (22.94 ± 2.87 pA/pF,
n = 6; Figures 6B,D), but these currents were found to be sig-
niﬁcantly blocked by strychnine (29.09 ± 2.63%, P < 0.001,
n = 6; Figures 6B,D,E). Additionally, the application of glycine
(3 mM) indeed produced strychnine-sensitive inward currents in
RFP-positive cells in rat cortices (30.32 ± 4.14 pA/pF, n = 6;
blocked by strychnine to 14.13 ± 2.99%, P < 0.001, n = 6;
Figures 6C,D,E). Thus, in the rat fetal neocortex, radially migrat-
ing neurons express GlyRs (Nimmervoll et al., 2011), and the
taurine-evoked inward currents are mainly mediated by these
GlyRs.
ENDOGENOUS TAURINE ACTIVATES GABAARs, PRODUCING TONIC
CURRENTS IN RADIALLY MIGRATING NEURONS
We next examined whether endogenous taurine activates
GABAARs in radially migrating cells in the fetal mouse neocortex.
GABAAR-mediated tonic currents were recorded under whole-cell
voltage-clamp conditions at −60 mV in RFP-positive cells located
in the SP region of the developing cortex at E17.5, and the cur-
rents were compared between GAD67+/+ and GAD67GFP/GFP
fetuses. The GABAAR-mediated components were revealed by
the application of 10 μM SR95531 (Figure 7A). There was
no difference in the GABAAR-mediated component observed
under normal conditions between GAD67+/+ (n = 5) and
GAD67GFP/GFP (n = 5) fetuses (P = 0.609 by Student’s t-
test; Figure 7C, left bars). The membrane capacitance of the
recorded cells was similar between the two types of fetuses
(GAD67+/+: 11.29 ± 0.97 pF, GADGFP/GFP: 8.57 ± 2.15 pF,
P = 0.283 by Student’s t-test). Application of the taurine trans-
porter inhibitor GES (300 μM) induced an inward shift of
the holding currents, which was reversed by the application of
SR95531 (Figure 7B). The baseline noise of the currents [root
mean square (rms) noise level; GAD67+/+: 1.42 ± 0.09 pA;
GADGFP/GFP: 1.80 ± 0.09 pA] was also enhanced by GES treat-
ment (GAD67+/+: 4.58 ± 0.99 pA, P = 0.030 by paired t-test;
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FIGURE 4 | Immunostaining to detect taurine and the taurine
transporter in the cerebral cortices of GAD67+/+ fetuses at E17.5.
(A) Photomicrograph showing the distribution of taurine in a coronal section
of the cortex. The section was counterstained with hematoxylin and eosin
(blue). CPu, caudate putamen; LGE, lateral ganglionic eminence; MGE,
medial ganglionic eminence; VP, ventral pallidum; Pir, piriform cortex.
(B) Enlarged view of the boxed area shown in (A). (C) Higher magniﬁcation
view of the SP area shown in (B). (D) Electron micrograph of a
taurine-immunolabeled section. Arrowheads indicate gold particles. M,
mitochondria; N, nucleus; R, ribosome; RER, rough endoplasmic reticulum.
(E) Photomicrograph of the distribution of the taurine transporter in a coronal
section of the cortex. (F) Enlarged view of the boxed area shown in (E).
GADGFP/GFP: 4.07 ± 0.22 pA,P < 0.001 by paired t-test) and sup-
pressed by SR95531 (GAD67+/+: 1.83 ± 0.30 pA, P = 0.025 by
paired t-test; GADGFP/GFP: 2.08 ± 0.15 pA, P = 0.001 by paired
t-test). Thus, GABAAR activity was increased in the presence of
GES, causing an increase in holding currents, while the currents
recorded in GAD67+/+ and GAD67GFP/GFP mice showed no sig-
niﬁcant difference in magnitude (P = 0.303, n = 5; Figure 7C,
right bars).
GES has been reported to activate GABAARs in cerebellar
granule cells (Mellor et al., 2000). To conﬁrm whether GES
acts on GABAARs or taurine transporters in radially migrating
neurons, we measured ambient taurine levels in cortical slices
incubated in medium with or without GES via HPLC. The taurine
levels in the cortices of GAD67+/+ fetuses were signiﬁcantly
enhanced in the presence of GES (P = 0.004 by Student’s t-
test; Figure 7D). Thus, GES blocked taurine transporters in
the cortices, thereby blocking the uptake of extracellular tau-
rine into the cells and increasing ambient taurine levels. These
data suggest that endogenous taurine can activate GABAARs
to produce tonic currents in the developing cerebral cortices
of both GAD67+/+ and in GAD67GFP/GFP fetuses. Further-
more, we conﬁrmed that the differences in the expression level
of GAD67 between the genotypes did not affect the ambient
taurine levels (GAD67+/+: 50.21 ± 5.79 fmol/μl·mg, n = 5;
GAD67+/GFP: 46.87 ± 3.85 fmol/μl·mg, n = 6; GAD67GFP/GFP:
45.74 ± 5.16 fmol/μl·mg, n = 4; P = 0.811 by ANOVA). Thus, the
Frontiers in Cellular Neuroscience www.frontiersin.org March 2014 | Volume 8 | Article 88 | 8
Furukawa et al. Taurine as endogenous GABAA agonist
FIGURE 5 | GABA-, taurine-, and glycine-evoked currents in
RFP-positive and -negative cells in GAD67+/+ fetuses.Typical traces of
the currents evoked by the applications of 10 μM GABA (A), 10 mM taurine
(B), and 3 mM glycine (C) in RFP-positive (left panels) and RFP-negative
(right panels) cells are shown. Black traces indicate the currents in the
absence of blockers; red traces are the currents obtained after the
application of 10 μM strychnine through bath perfusion in the same cells;
and gray traces are the currents recorded after the further addition of 10 μM
SR95531 to the bath solution. VH was −60 mV. (D)The means ± SEMs of
the peak current densities of the agonist-evoked currents in RFP-positive
(left panel) and RFP-negative (right panel) cells in the absence and presence
of strychnine (STR) and after the addition of SR95531 are plotted.
(E) Effects of blockers on agonist-evoked currents. The peak current
densities in the absence of blockers were normalized to 100%.
presence of GABAAR-mediated tonic currents in GAD67GFP/GFP
fetuses under normal conditions with amplitudes similar to those
found in GAD67+/+ fetuses (Figure 7C, left bars) suggests that
taurine, rather than GABA, contributes to the generation of the
tonic currents in GAD67GFP/GFP fetuses.
FIGURE 6 | GABA-, taurine-, and glycine-evoked currents in
RFP-positive cells in rat fetuses at E18.5.Typical traces of the currents
evoked by the application of 10 μM GABA (A), 10 mM taurine (B), and
3 mM glycine (C) in RFP-positive cells are shown. Black traces indicate the
currents in the absence of blockers; red traces are the currents obtained
after the application of 10 μM strychnine through bath perfusion in the
same cells; and gray traces are the currents recorded after the further
addition of 10 μM SR95531 to the bath solution. VH was −60 mV. (D)The
means ± SEMs of the peak current densities in the absence and presence
of strychnine (STR) and after the addition of SR95531 are plotted.
(E) Effects of blockers on agonist-evoked currents. The peak current
densities in the absence of blockers were normalized to 100%.
MATERNAL ADMINISTRATION OF D-CSA DECREASES AMBIENT
TAURINE LEVELS AND GABAAR-MEDIATED TONIC CURRENTS IN BOTH
WILD-TYPE AND GAD67 KNOCK-IN FETUSES
If taurine is the major endogenous agonist of GABAARs in
GAD67GFP/GFP fetuses, inhibition of taurine production in the
mother would have an effect on radial migration in the fetuses,
similar to the effect of blockade of GABAARs; i.e., facilita-
tion of migration (Figure 3). To investigate this hypothesis, we
intraperitoneally injected a competitive inhibitor of taurine pro-
duction, D-CSA, into pregnant mice every 12 h beginning at
E14.5, after in utero electroporation for cell labeling and exam-
ined its effects on ambient taurine levels, GABAAR activation
and the radial migration of neurons in the fetal neocortices at
E17.5.
First, we determined the ambient taurine levels in cortical
slices from GAD67+/+ fetuses via HPLC. The taurine lev-
els were signiﬁcantly decreased by maternal administration of
D-CSA (Control: 50.21 ± 5.79 fmol/μl·mg, n = 5; D-CSA:
29.42 ± 2.69 fmol/μl·mg, n = 5; P = 0.012 by Student’s t-test;
Figure 8A). Next, we examined the effects of decreased taurine lev-
els on GABAAR-mediated tonic currents in RFP-positive, radially
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FIGURE 7 | GABAARs in radially migrating neurons are activated by
endogenous taurine. (A)Typical trace of a GABAAR-mediated tonic current
in an RFP-positive cell in the SP under normal conditions. VH was −60 mV.
(B) SR95531-sensitive inward current induced by the application of GES. The
baseline currents immediately before (for 5 s) the initiation and the cessation
of SR95531 application were averaged, to determine the tonic currents based
on their difference. (C) Averaged tonic current amplitudes before and after
GES application. There were no signiﬁcant differences between the
GAD67+/+ (n = 5) and GAD67GFP/GFP (n = 5) mice. (D) HPLC
measurements of the taurine concentrations in the cortical slice incubation
medium either without (Control, n = 5) or with GES (300 μM, n = 4). Error
bar: mean ± SEM. *P < 0.01.
migrating neurons in the SP and CP regions of the cortical slices.
In both the SP and CP regions, maternal D-CSA administration
signiﬁcantly reduced the amplitudes of the tonic currents, not
only in GADGFP/GFP fetuses (Control SP: 2.10 ± 0.27 pA, n = 5;
D-CSA SP: 0.61 ± 0.13 pA, n = 4; P = 0.002 by Student’s t-
test; Figures 8B,C, third bar group from the left; Control CP:
1.03 ± 0.16 pA, n = 5; D-CSA CP: 0.55 ± 0.11 pA, n = 5;
P = 0.042 by Student’s t-test; Figure 8C, rightmost bar group)
but also in GAD67+/+ fetuses (Control SP: 2.39 ± 0.48 pA, n = 5;
D-CSA SP: 0.47 ± 0.11 pA, n = 5; P = 0.004 by Student’s t-
test; Figure 8C, leftmost bar group; Control CP: 1.58 ± 0.26 pA,
n = 6; D-CSA CP: 0.91 ± 0.14 pA, n = 6; P = 0.046 by Student’s
t-test; Figure 8C, second bar group from the left). There was
no difference in the membrane capacitance of the recorded cells
observed between Control and maternal D-CSA-treated fetuses
(GAD67+/+; 11.29 ± 0.97 pF in Control SP, 12.59 ± 3.19 pF
in D-CSA SP, P = 0.708 by Student’s t-test, 8.58 ± 0.91 pF in
Control CP, 7.02 ± 1.22 pF in D-CSA CP, P = 0.334 by Student’s
t-test; GADGFP/GFP; 8.57 ± 2.15 pF in Control SP, 8.50 ± 1.22
pF in D-CSA SP, P = 0.979, by Student’s t-test, 8.63 ± 1.53 pF
in Control CP, 8.86 ± 1.29 pF in D-CSA CP, P = 0.913, by
Student’s t-test). The signiﬁcant suppression of tonic currents
observed in even GABA-rich GAD67+/+ fetuses suggests that tau-
rine plays a major role as an endogenous agonist of GABAARs,
producing tonic currents irrespective of the genotype involved,
at least in the SP and CP regions of the fetal cerebral cortex at
E17.5.
RADIAL MIGRATION IS ACCELERATED BY REDUCED AMBIENT TAURINE
LEVELS IN GAD67-GFP KNOCK-IN MICE
Next, we examined the effects of maternal D-CSA adminis-
tration on the radial migration of neurons in the fetal neo-
cortex. The distribution patterns of RFP-positive cells with
and without D-CSA treatment were compared in GAD67+/+,
GAD67+/GFP, and GAD67GFP/GFP fetuses. In the GAD67+/GFP
and GAD67GFP/GFP fetuses, the distribution pattern of RFP-
labeled cells was altered signiﬁcantly by D-CSA administration
(P = 0.046 in GAD67+/GFP, Figure 9C, middle; P = 0.015 in
GAD67GFP/GFP; Figures 9A–C, right; χ2-test). In GAD67+/GFP
andGAD67GFP/GFP fetal cortices, the number of RFP-positive cells
was increased in the CP (P = 0.023 in GAD67+/GFP; P = 0.012 in
GAD67GFP/GFP; MWU-test) and decreased in the SP (P = 0.040
in GAD67+/GFP; GAD67GFP/GFP; P = 0.012) by D-CSA admin-
istration. In GAD67GFP/GFP fetuses, the number of RFP-positive
cells in the IZ was also signiﬁcantly reduced (P = 0.022). Thus,
radial migration in GAD67+/GFP and GAD67GFP/GFP fetuses was
accelerated by the depletion of taurine. Although the change in
the pattern was not signiﬁcant in GAD67+/+ fetuses (P = 0.169;
Figure 9C, left), a similar trend was apparent. In addition,
the distribution patterns of RFP-positive cells with and with-
out D-CSA treatment were compared in GAD67GFP/GFP fetuses
at E16.5 and E18.5 and were not found to be signiﬁcantly
altered by D-CSA administration (E16.5: P = 0.488, Figure 9D,
left, χ2-test; E18.5, P = 0.854, Figure 9D, right, χ2-test).
Thus, the speed of radial migration during the period between
E16.5 and E18.5 was increased by D-CSA, as early exit from
the SP was apparent at E17.5, although the ﬁnal distribution
of E14.5-born neurons at E18.5 was not disturbed by D-CSA
(Figure 9D, right). These data suggest that in GAD67-GFP
knock-in fetuses, taurine, rather than GABA, regulates the radial
migration of neurons by activating GABAARs and slowing the
speed of migration.
TAURINE ACTIVATES A FRACTION OF GABAARs IN RADIALLY
MIGRATING NEURONS
The afﬁnity of GABAARs for taurine was recently reported to
depend on the subunit composition of GABAARs (Kletke et al.,
2013). To examine how large a fraction of GABAARs are activated
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FIGURE 8 | Effects of maternal D-CSA administration on ambient
taurine levels and GABAAR-mediated tonic currents in the fetal
neocortex. (A) Ambient taurine levels in fetal cortical slices determined via
HPLC. E17.5 GAD67+/+ fetuses were obtained from pregnant mice
injected with either saline (Control, n = 5) or D-CSA (n = 5). (B)Typical
traces of GABAAR-mediated tonic currents recorded in RFP-positive
neurons in the SP regions of GAD67GFP/GFP fetal cortical slices. The
fetuces were obtained from saline- (upper trace) and D-CSA-treated (lower
trace) pregnant GAD67+/GFP mice. (C) Averaged tonic current amplitudes
in the SP and the CP regions of cortical slices obtained from GAD67+/+
(left bar group) and GAD67GFP/GFP (right bar group) fetuses either without
(gray bars) or with (white bars) maternal D-CSA injection. The numbers in
parentheses indicate the number of samples. *P < 0.05, **P < 0.01. Error
bar: mean ± SEM.
by taurine in radially migrating neurons, we compared the cur-
rents evoked by GABA and taurine in the same radially migrating
neuron in the SP region of GAD67+/+ fetal cortical slices. For
this purpose, we ﬁrst recorded the currents evoked by the topical
application of 10 μM GABA, followed by bath application of tau-
rine at 10 mM. Taurine perfusion induced inward currents that
were much weaker than those evoked by GABA, while taurine did
not induce signiﬁcant current desensitization during its perfusion
(Figure 10Aa). When GABA was again applied in the presence
of taurine, the amplitudes of the GABA-evoked inward currents
were 49.97 ± 5.83% (n = 10) of those prior to taurine perfu-
sion (Figures 10Ab,B, right). The peak levels of the GABA-evoked
currents observed during GABA application were unchanged by
taurine perfusion (Figures 10Ab,B, left; P = 0.867 by paired t-
test, n = 10). Thus, taurine activates only a fraction (∼49.97%)
of GABAARs, with a much lower afﬁnity than GABA in radially
migrating neurons.
TAURINE IS RELEASED THROUGH VOLUME-SENSITIVE ANION
CHANNELS IN THE DEVELOPING CEREBRAL CORTEX
Finally, we examined how taurine is released in the develop-
ing cerebral cortex. Some studies have reported that the taurine
release induced by hypotonic shock in adult brain tissues can
be blocked by anion channel blockers (Schousboe et al., 1991;
Oja and Saransaari, 1992; Haskew-Layton et al., 2008). Thus,
volume-sensitive anion channels are likely to be responsible for
this taurine release (Haskew-Layton et al., 2008). To determine
whether such anion channels are involved in taurine release in
the fetal cerebral cortex, we examined the effects of anion chan-
nel blockers and a hypotonic medium on the release of taurine
from acute cortical slices obtained from GAD67+/+ fetuses at
E17.5.
To observe these effects clearly, ﬁrst we preloaded the slices
with 10 mM taurine by preincubating them in taurine-containing
medium for 1 h. This was expected to enhance the intracellular
taurine content, thereby increasing the taurine release ﬂux from
the cells. Indeed, the ambient taurine level measured via HPLC
after preloading was greatly enhanced (Figure 11, fourth bar from
the left). This enhancement was suppressed by adding the taurine
transporter blocker GES (300 μM) to the preincubation medium
(Figure 11, ﬁfth bar from the left). Preloading with 1 mM tau-
rine had no detectable effect (Figure 11, third bar from the left),
suggesting that the rate of taurine uptake by taurine transporters
under these loading conditions was balanced by the rate of taurine
release from the cells. In addition to preloading the cortical slices
with 10 mM taurine, we added GES during the period of taurine
levelmeasurement to isolate the taurine release ﬂux. However,GES
didnot further enhance themeasured taurine level (Figure 11, ﬁfth
bar from the right).
Application of a global inhibitor of anion channels, DIDS
(1 mM), to the measurement medium markedly reduced tau-
rine release (Figure 11, fourth bar from the right). This
reduction was still clearly observable, even in the absence of
GES treatment (Figure 11, sixth bar from the right). Treat-
ment with a more speciﬁc inhibitor of volume-sensitive anion
channels, DCPIB (10 and 100 μM), also markedly suppressed
taurine release in a dose-dependent manner (Figure 11, second
and third bars from the right). Moreover, the taurine release
was markedly enhanced in the hypotonic medium, which is
the most effective activator of volume-sensitive anion channels
(Figure 11, rightmost bar). Thus, taurinemust be released through
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FIGURE 9 | Effects of maternal D-CSA administration on the distribution
of radially migrating neurons in the fetal neocortex. (A,B) Fluorescent
micrographs showing the distribution of RFP-labeled radially migrating cells in
cortical sections from GAD67GFP/GFP fetuses at E17.5. Saline (Control) (A) or
D-CSA (B) was administered to the mothers every 12 h for 3 days (E14–17).
(C)The averaged proportions of radially migrating cells in the CP, SP, IZ, and
SVZ/VZ regions of cortical slices obtained from GAD67+/+ (leftmost),
GAD67+/GFP (middle), and GAD67GFP/GFP (rightmost) fetuses at E17.5 with
(yellow bars) and without (blue bars) maternal D-CSA administration. (D)The
averaged proportions of radially migrating cells in cortical slices obtained from
GAD67GFP/GFP fetuses at E16.5 (left) and E18.5 (right) either with (yellow
bars) or without (blue bars) maternal D-CSA administration. The numbers in
parentheses indicate the number of fetuses examined. $P < 0.05 by χ2-test.
*P < 0.05 by MWU-test. Error bar: mean ± SEM. Scale bar: 200 μm.
volume-sensitive anion channels in the developing cerebral
cortex.
DISCUSSION
In the present study, we showed that radial migration in the
developing mouse cerebral cortex was modulated by GABAAR
activation in ambient GABA-deﬁcient GAD67-GFP knock-in
mice. Ambient taurine, which abundantly expressed in the
SP and MZ, acts as an endogenous agonist of GABAAR to
tonically activate GABAARs and attenuate the speed of radial
migration.
GABAARs have been reported to regulate neuronal migration
in several cell types and are known to act as a stop signal for
radially migrating neurons in the developing cortex (Owens and
Kriegstein, 2002; Heck et al., 2007; Manent and Represa, 2007;
Wang et al., 2013; for a review, see Egawa and Fukuda, 2013).
However, the effect of GABAAR activation on neuronal migration
has mostly been investigated in vitro using GABAAR antagonists
(Behar et al., 1996, 1998, 2000; Bolteus and Bordey, 2004). In
this study, radially migrating cells, labeled via in utero electro-
poration at E14.5, were identiﬁed in the cerebral cortex at E17.5.
We found that the distribution pattern of the radially migrating
cells was normal, even in GABA-deﬁcient GAD67GFP/GFP fetuses.
In addition, electrophysiological recordings demonstrated that
the GABAAR sensitivities of radially migrating cells did not
differ among the different genotypes of GAD67-GFP knock-in
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FIGURE 10 | Comparison of GABA-evoked currents before and during
taurine application in radially migrating neurons in the SP region of
the fetal neocortex. (Aa)Typical trace of the currents evoked via the puff
application of 10 μM GABA before and during bath perfusion of 10 mM
taurine in a single RFP-positive neuron. The GABA-evoked currents boxed
with dashed colored lines were superimposed in (Ab). VH was −60 mV.
(B)The peak levels of GABA-evoked currents before (Control) and during
taurine application (Taurine) are plotted and compared (left, n = 10). The
levels were not signiﬁcantly altered by taurine application (P = 0.867 by
paired t -test). The amplitudes of GABA-evoked currents before (Control)
and during taurine application (Taurine) are plotted and compared (right).
The amplitudes were signiﬁcantly altered by taurine application (P = 0.004
by paired t -test).
fetuses. These results are consistent with a previous report show-
ing that GAD65/67 double knock-out embryonic mouse brains
do not show any histological abnormality (Ji et al., 1999). Fur-
thermore, we demonstrated that sustained blockade of GABAARs
via SR95531 administration accelerated radial migration in the
cerebral cortex of GABA-deﬁcient GAD67GFP/GFP fetuses. These
ﬁndings imply that activation of GABAAR indeed affects radial
migration, but that GABAARs are not necessarily activated by
endogenous GABA.
FUNCTIONAL EXPRESSION OF GABAAR, BUT NOT GlyR, IN RADIALLY
MIGRATING CELLS IN THE FETAL MOUSE NEOCORTEX
GABA-induced inward currents were observed in all recordings
obtained from RFP-labeled cells, which is consistent with previ-
ous studies demonstrating the presence of functional GABAARs in
these cells (LoTurco et al., 1995; Owens et al., 1996). RFP-positive,
radially migrating cells showed GABAAR-mediated currents in
response to taurine application. Interestingly, none of the RFP-
positive cells in which recordings were made showed glycine-
induced currents. These results suggest that the GABAARs, but
not GlyRs, on radially migrating cells were activated by taurine
in the fetal mouse neocortex. Functional expression of GlyRs
has been reported in the fetal and neonatal rat cortex (Malosio
et al., 1991; Flint et al., 1998; Nimmervoll et al., 2011). Accord-
ingly, in E18.5 rat fetuses, we found that radially migrating
cells labeled via in utero electroporation 3 days before record-
ings were performed exhibited glycine-induced inward currents
(Figure 6). In addition, in mouse fetuses, some of RFP-
negative cells that were presumably generated earlier than the
RFP-positive cells responded to the application of glycine by
producing large currents. Considering these results, the expres-
sion of functional GlyRs might differ between rats and mice.
In mice, GlyRs may be expressed after the migratory period of
corticogenesis, in contrast to those in rats (Nimmervoll et al.,
2011).
The functional properties of GABAARs and the afﬁnity of tau-
rine are subunit dependent. Previous studies have found that
taurine acts on a speciﬁc subtype of GABAAR containing the β2
subunit (Bureau and Olsen, 1991; Kash et al., 2004). Kletke et al.
(2013) also reported that the efﬁcacy of taurine is independent
of the α subunit type and is instead determined by the β subunit
type based on recombinant studies. Furthermore, δ-containing
receptors are more potently and efﬁciently gated by taurine than
γ-containing receptors (Jia et al., 2008; Kletke et al., 2013). Con-
sidering these ﬁndings, taurine is likely to potently activateαxβ1/2δ
subunit-containing GABAARs. GABAAR subunits α2–α5, β1–β3,
γ1–γ2, and δ are expressed in immature cortical cells, and these
subunits are developmentally regulated (Gambarana et al., 1991;
Araki et al., 1992; Laurie et al., 1992; Cheng et al., 2006; Peden et al.,
2008; Cuzon Carlson and Yeh, 2010). Although the expression of
GABAAR subunits in radially migrating cells remains unclear, it is
possible that they may express the components that mediate the
actions of taurine.
AMBIENT TAURINE TONICALLY ACTIVATES GABAAR AND MODULATES
RADIAL MIGRATION IN THE FETAL CEREBRAL CORTEX
Previous studies have shown that tonic activation of GABAAR
is evident in certain embryonic neurons before synapse forma-
tion has taken place (Valeyev et al., 1993; LoTurco et al., 1995;
Owens et al., 1999; Farrant and Nusser, 2005; Cancedda et al.,
2007). While we also demonstrated that GABAARs were tonically
activated in the fetal cerebral cortex, GABAAR-mediated tonic
currents were detected even in GABA-deﬁcient GAD67GFP/GFP
fetuses. We found that taurine and its transporter are expressed
at particularly high levels in the SP and MZ of the fetal cerebral
cortex and that depletion of taurine through maternal D-CSA
administration greatly reduces the recorded tonic currents, not
only in the SP but also in the CP, in both GAD67+/+ and
GAD67GFP/GFP fetuses. Moreover, although it did not reach sta-
tistical signiﬁcance, there was a trend of smaller tonic currents
observed in the CP compared to the SP, even under control (D-
CSA-untreated) conditions (Figure 8C). This might reﬂect the
differences in ambient taurine levels between the SP and CP
sensed by GABAARs. These ﬁndings suggest that in the cere-
bral cortex of fetal mice, taurine might play a major role as an
endogenous agonist of GABAARs and that the GABAARs in radi-
ally migrating cells are activated tonically by ambient taurine,
rather than GABA. However, our results do not fully exclude
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FIGURE 11 | Effects of anion channel blockers on taurine release in
the developing neocortex. Each bar represents the taurine
concentration determined via HPLC in the measurement medium
containing cortical slices from GAD67+/+ fetuses at E17.5, either without
or with the inhibitors indicated below the bar (“incubation”). The loading
conditions, either without or with taurine (1 or 10 mM) and/or GES
(300 μM), before the measurements were performed are also indicated
just beneath the bar (“loading”). DIDS (1 mM) and DCPIB (10 or
100 μM) were dissolved in incubation media. The numbers in
parentheses at the bottom of the bars indicate the number of samples.
One sample was obtained from one fetus. #*$P < 0.05, $$P < 0.01.
Error bar: mean ± SEM.
the possibility that some component of GABAARs is activated
by endogenous GABA. The afﬁnity of GABAARs for GABA is
more than three orders of magnitude higher than for taurine
(Kletke et al., 2013), which was also indicated by our results
(Figure 10). Therefore, even though the applied D-CSA treat-
ment decreased the basal taurine level in the fetal cerebral cortex
by only 40% (Figure 8A), it is possible that the component
of tonic GABAAR currents that remains after D-CSA treatment
(Figure 8C) might be due to the action of endogenous GABA to
some extent.
The amplitude of tonic GABAAR currents in the SP,which were
found to be mostly caused by taurine action, was approximately
2.5 pA inbothGAD67+/+ andGAD67GFP/GFP fetuses (Figures 7C
and 8C). However, these currents were recorded in the presence
of a high intracellular Cl− concentration (122 mM), introduced
through whole-cell patch pipettes. As the intracellular Cl− level
under physiological conditions must be lower than that in our
experiments, the tonic currents that occur under physiological
conditions must be smaller than those we measured because of
the weaker driving force for Cl− movement. In previous reports,
the resting membrane potential and the reversal potential for
GABAAR-mediated currents measured by gramicidin-perforated
patch-clamp recordings were reported to be −65 and −43 mV,
respectively, in rat CP cells at E19 or E18.5 (Owens et al., 1996;
Inoue et al., 2012). Assuming conditions similar to these previous
reports, the amplitude of tonic currents we measured at the hold-
ing potential of −60 mV with an Cl− equilibrium potential of
−2 mV would correspond to ∼0.9 pA. The membrane resistance
of the SP cells estimated in the present study, based on the holding
current level at −60 mV (10.08 ± 0.79 pA, n = 5), was approx-
imately 6 G. Thus, the 0.9 pA tonic currents may depolarize
the cells by 5.4 mV. Nevertheless, because Cs+ salts were used in
our pipette solution to block K+ channels, the 6 G membrane
resistance must be an overestimated value, and the degree of depo-
larization elicited by tonic currents in SP cells under physiological
conditions would therefore be no greater than 5 mV.
When the taurine-mediated tonic GABAAR currents were
reduced via maternal D-CSA administration, the distribution pat-
tern of RFP-positive cells was signiﬁcantly changed, especially
in GAD67GFP/GFP fetuses, indicating an increase in the fraction
of RFP-positive cells in the CP and a reciprocal decrease in the
SP and IZ at E17.5 (Figures 9A–C). This pattern mimicked the
change in distribution caused by GABAAR blockade (Figure 3).
These results clearly indicate that the reduction of GABAAR activ-
ity in the SP caused by taurine depletion accelerates the exit of
radially migrating neurons from the SP. Thus, taurine slows the
speed of radially migrating neurons across the SP through activat-
ing GABAARs in these neurons. In the cortices of GAD67+/GFP
fetuses, in which the ambient GABA level is reduced by 32% (Mor-
ishima et al., 2010), a similar change in distribution was elicited by
taurinedepletion,while the changeobserved inGAD67+/+ fetuses
was subtle (Figure 9C). As such, the ambient GABA levels could
also regulate radial migration, presumably through activating the
GABAARs in regions other than the SP.
The mechanism underlying the regulation of the speed of
migrating neurons via taurine-mediated GABAAR activation has
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not yet been resolved. It has been demonstrated in immature
cortical neurons that GABAAR activation is required to main-
tain intracellular oscillatory Ca2+ signaling (Behar et al., 1996;
Owens et al., 1996; Garaschuk et al., 2000; Heck et al., 2007).
Thus, the stop signal for migration generated by taurine is
also expected to be mediated by the Ca2+ signaling. By con-
trast, in the developing cerebellum, the migration of granule
neurons has been reported to be stopped by the loss of intra-
cellular Ca2+ signaling (Kumada and Komuro, 2004). Hence,
the role of intracellular Ca2+ signaling in neuronal migration
seems to differ between the cortex and the cerebellum. Never-
theless, the notion that the action of taurine in the cerebellum
also maintains Ca2+ signaling in granule cells through activating
GABAARs would be consistent with a previous report indicat-
ing a delay in granule cell migration in taurine-deﬁcient kittens
(Sturman et al., 1985).
Even when the radial migration of neurons in the developing
cortex was accelerated by taurine depletion at E17.5, the destina-
tion of the migrating neurons at E18.5 was not affected by taurine
depletion (Figure 9D). This suggests that the effect of taurine-
mediated GABAAR activation on radial migration is temporary,
and a different process might be involved in the ﬁnal maturation
of the cortex. Nevertheless, it is possible that the early exit of
migrating neurons from the SP caused by taurine depletion may
affect ﬁnal circuit formation and/or the function of the neurons
after birth in some manner. To examine this possibility, it will be
necessary to follow the effect of taurine depletion on the matura-
tion of the cortex in GAD67+/GFP mice in detail even after birth
because the GAD67GFP/GFP genotype is lethal immediately after
birth due to severe cleft palate, which has been well established in
GAD67 knock-out mice (Asada et al., 1997).
AMBIENT TAURINE IS TAKEN UP BY TAURINE TRANSPORTERS AND
RELEASED VIA VOLUME-SENSITIVE ANION CHANNELS
Taurine transporters are highly expressed in the neocortex (Smith
et al., 1992). These transporters belong to a family of Na+ and
Cl−-dependent neurotransmitter transporters that mediate the
uptake of taurine into cells under resting conditions (Molchanova
et al., 2004; Tappaz, 2004). Because taurine uptake is driven by
the membrane gradient of Na+ and Cl−, taurine transporter
activity can be reversed by stimuli that alter this gradient (Oja
et al., 1985; Oja and Kontro, 1987; Takuma et al., 1996). In the
present study, the ambient taurine level in fetal cortical slices
was increased via the application of GES. In addition, taurine
release from 10 mM taurine-loaded cortical slices was decreased
by GES application during the taurine loading period. Further-
more,GABAAR-mediated tonic currents of SP cells were enhanced
by GES application. These results are compatible with the normal
taurine transporter function of extracellular taurine uptake. Thus,
ambient taurine is taken up by taurine transporters in the mouse
fetal neocortex.
In the present study, we observed ambient taurine levels in
the fetal cerebral cortex via HPLC. The released taurine concen-
tration was 45.7–50.2 fmol/μl·mg, while no released GABA was
detectable. As our HPLC system is able to detect GABA at the
0.05 fmol/μl·mg level (Morishima et al., 2010), the taurine levels
in our study were more than 1,000 times higher than those of
GABA in the cerebral cortex of E17.5 mice. Furthermore, in tau-
rine loading experiments, the released taurine concentration was
increased by loading with 10 mM taurine but was not changed by
1mM taurine loading. These data suggest that the ambient taurine
concentration in the fetal cerebral cortex may be in the millimolar
range.
We showed that taurine was expressed in the SP and MZ of
the cerebral cortex at E17.5 through immunohistochemical anal-
ysis. Immunoelectron microscopic analysis demonstrated that
taurine was located within immature neurons, whereas it was not
detectable in presynaptic structures. These results imply that the
release of taurine may be controlled in a non-vesicular manner,
which is in accord with previous studies suggesting that taurine
can be released as an osmolyte through non-vesicular systems in
neurons and glial cells (Calvert and Shennan, 1998; Flint et al.,
1998; Mongin et al., 1999; Mulligan and MacVicar, 2006). Pre-
vious studies have also shown that taurine can be released via
volume-sensitive anion channels (Fugelli andThoroed,1986; Jack-
son and Strange, 1993; Hall, 1995; Shennan, 1999; Haskew-Layton
et al., 2008). However, there are limited data on the release of
taurine in the fetal nervous system, despite its important role
in functional development (Sturman et al., 1985; Palackal et al.,
1986); non-synaptic and hypo-osmotic taurine release has been
observed in the immature cortex of rats (Flint et al., 1998; Kilb
et al., 2008). Our data showed that administration of DIDS, a
broadCl− channel blocker, andDCPIB,a speciﬁc volume-sensitive
anion channel blocker, blocked taurine release, while a hypo-
tonic medium stimulated taurine release. These results provide
evidence that taurine release in the fetal cerebral cortex is medi-
ated by volume-sensitive anion channels (Jackson and Strange,
1993; Shennan, 1999; Molchanova et al., 2004; Haskew-Layton
et al., 2008).
The involvement of volume-sensitive anion channels in the
radial migration of neurons is an interesting issue. Volume-
sensitive anion channels are typically activated in response to cell
swelling (Okada, 1997), but they may also be activated without
swelling when certain types of chemical mediator or transmitter
act on the cell (Liu et al., 2009; Okada et al., 2009). Moreover,
it has recently been demonstrated in mouse astrocytes that the
transmitter-induced activation of volume-sensitive anion chan-
nels is locally controlled via regions of high concentrations of
intracellular Ca2+ in the immediate vicinity of Ca2+-permeable
ion channel pores, or so-called “Ca2+ nanodomains” (Akita and
Okada, 2011; Akita et al., 2011). Therefore, if the volume-sensitive
anion channels located on the leading edges of migrating neurons
are activated in response to taurine-induced intracellular Ca2+
signaling in a similar manner to that observed in astrocytes, a
net efﬂux of Cl− and K+ should ensue according to their electro-
chemical gradients, which should accompany an obligatory water
efﬂux. This may facilitate shrinkage of the leading edge and slow
the migrating neurons (Schwab et al., 2012). Furthermore, taurine
release through the activated channels may send synchronizing
signals to adjacent neurons. Exploring the mechanism of the acti-
vation of the volume-sensitive anion channels and their roles in
the fetal neocortex in detail would therefore shed light on the mys-
tery of fetal brain development, which needs to be addressed in
future studies.
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CONCLUSION
We provide new evidence that ambient taurine in the mouse
fetal cerebral cortex modulates radial migration. Ambient taurine
exhibits a relatively wide distribution with relatively high levels
in the SP and is released via volume-sensitive anion channels
to tonically activate GABAARs and slow radial migration in the
developing cerebral cortex.
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